Intrinsic Value of S&P & Nasdaq Contact Us

AstraZeneca PLC AZN NYSE

NYSE • Healthcare • Drug Manufacturers - General • GB • USD

SharesGrow Score
64/100
4/7 Pass
SharesGrow Intrinsic Value
$411.20
+101.2%
Analyst Price Target
$105.50
-48.4%

Stock Statistics — AZN

AstraZeneca PLC (AZN) has a market capitalization of $316.85B and trades at $204.38. The 52-week range is 122.48-212.71.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 15.5, Earnings Per Share (EPS) of $13.20, annual revenue of $58.74B.

The stock has a beta of 0.28, a last dividend of $3.1778, operates in the Healthcare sector.

Trading Data
Current Price$204.38
52-Week Range122.48-212.71
Volume2.21M
Avg Volume (30D)2.84M
Market Cap$316.85B
Beta (1Y)0.28
Last Dividend$3.1778
Company
IPO Date1993-05-12
Employees94,300
CEOPascal Claude Roland Soriot
CountryGB
ExchangeNYSE
CurrencyUSD
ISINGB0009895292
CUSIPG0593M107
Income (Latest Year)
Revenue$58.74B
Gross Profit$48.11B
EBITDA$19.83B
Operating Income$13.74B
Net Income$10.26B
EPS$13.20
EPS Diluted$13.08
Shares Outstanding$775M
Balance Sheet (Latest Year)
Total Assets$114.07B
Current Assets$28.72B
Cash & ST Investments$5.74B
Total Liabilities$65.36B
Total Debt$29.7B
Net Debt$23.99B
Total Equity$48.72B
Debt / Equity0.61
Valuation Ratios
P/E Ratio15.5
P/S Ratio5.39
P/B Ratio6.5
EV/EBITDA (approx)16
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message